TipRanks Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 2955
- Sources here
- 17
- Companies here
- 29
Active search
2955 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Scholastic director Kaya Henderson sells $130,812 in stock
Scholastic Corp. director Kaya Henderson sold 3,250 shares of company stock for $130,812 on August 6, 2026. Following the sale, Henderson beneficially owns 7,113 shares. The transaction occurred amidst Scholastic reporting Q4 earnings that met profit forecasts but missed revenue expectations, with the stock …
GXO Logistics (GXO) Returned To Profitability, Is The Stock Still Undervalued?
GXO Logistics (GXO) has returned to profitability in the first half of 2026 with sales of US$3,441 million for the quarter. While the stock has seen declining long-term shareholder returns, its share price has recently shown a modest 3.05% return over 90 days. The …
ABN AMRO Bank N.V. Buys Shares of 101,679 Wabtec $WAB
ABN AMRO Bank N.V. has purchased a new position of 101,679 shares in Wabtec (NYSE:WAB) during the second quarter, valued at approximately $27.39 million, representing 0.06% of the company. Other institutional investors also adjusted their stakes in Wabtec, with significant buying activity reported. Wabtec …
Nexstar Media Group, Inc. $NXST Shares Purchased by Bank of America Corp DE
Bank of America Corp DE increased its stake in Nexstar Media Group (NXST) by 17% in Q1, holding 173,269 shares worth $31.3 million. Institutional investors collectively own 95.3% of the company, which holds a "Moderate Buy" consensus rating from analysts with an average price …
ABN AMRO Bank N.V. Takes $21.52 Million Position in Quest Diagnostics Incorporated $DGX
ABN AMRO Bank N.V. recently acquired a new position in Quest Diagnostics Incorporated, purchasing 101,667 shares valued at approximately $21.52 million during the second quarter. This investment makes ABN AMRO Bank N.V. an approximate 0.09% owner of the medical research company. Other institutional investors …
Solstice Advanced Materials, Inc. (SOLS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solstice Advanced Materials, Inc. (NASDAQ: SOLS) following a significant stock price drop after its announcement to acquire Element Solutions for $14.5 billion. Despite the CEO's positive outlook on the acquisition, …
ETFs Investing in Prestige Consumer Healthcare Inc Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold stocks of Prestige Consumer Healthcare Inc. The list, sorted by market value, includes various ETFs with details such as issuer, management style, focus, expense ratio, assets under management (AUM), price, change, …
XPO (XPO) Could Be 9% Undervalued After Freight Demand Recovery Gains Pace
XPO (XPO) is attracting investor attention due to a recovery in freight demand, growing shipments, and tonnage, coupled with tighter transport capacity. Despite a significant year-to-date share price return, Simply Wall St's analysis suggests XPO could be 9% undervalued with a fair value of …
(DXYZ) as a Liquidity Pulse for Institutional Tactics
The article analyzes Destiny Tech100 Inc. (NASDAQ: DXYZ), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe signal strengths …
Walleye Capital LLC Purchases New Stake in Aquestive Therapeutics, Inc. $AQST
Walleye Capital LLC has acquired a new stake of 282,568 shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST), valued at approximately $1.18 million. Institutional investors collectively hold 32.45% of the company's stock, while insider ownership stands at 6.81%. Despite a wider-than-expected quarterly loss, analysts maintain a …
Pictet Asset Management Holding SA Has $26.75 Million Stock Position in Wabtec $WAB
Pictet Asset Management Holding SA significantly reduced its stake in Wabtec (NYSE:WAB) by 20.3% in Q2, now holding 99,209 shares valued at $26.75 million. Other institutional investors adjusted their positions, with some increasing holdings and others like Sumitomo Mitsui Trust Group Inc. growing its …